Atrial fibrillation: The role of atrial defibrillation

被引：0

作者：

Santini, M ^{[1
]}

Ricci, R ^{[1
]}

机构：

[1] San Filippo Neri Hosp, Dept Cardiol, I-00135 Rome, Italy

来源：

JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY | 2003年 / 9卷 / 02期

关键词：

atrial fibrillation; atrial defibrillator; dual chamber defibrillator; internal cardioversion; shock tolerance;

D O I：

10.1023/A:1026244726090

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Dual defibrillator implantation represents an emerging option to treat patients with drug refractory atrial fibrillation. Atrial antitachycardia pacing and cardioversion have been demonstrated to be highly effective in treating spontaneous tachyarrhythmias and may reduce atrial fibrillation burden by preventing atrial remodeling. Device implantation has been associated to improved quality of life and reduced hospitalization rate. Patient selection and tailored device programming are critical as regard to clinical outcome. Individual psychological profile analysis as well as underlying heart disease and atrial fibrillation clinical patterns represent the main drivers for the right strategy. Controlled studies are needed in order to define the subset of patients who can benefit more from device implantation.

引用

页码：229 / 233

页数：5

共 23 条

[1] Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator [J].

Adler, SW ;

Wolpert, C ;

Warman, EN ;

Musley, SK ;

Koehler, JL ;

Euler, DE .

CIRCULATION, 2001, 104 (08) :887-892

[2] Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator - A psychometric study [J].

Chevalier, P ;

Verrier, P ;

Kirkorian, G ;

Touboul, P ;

Cottraux, J .

PSYCHOTHERAPY AND PSYCHOSOMATICS, 1996, 65 (01) :49-56

[3] Current concepts - Implantable devices for the treatment of atrial fibrillation [J].

Cooper, JM ;

Katcher, MS ;

Orlov, MV .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (26) :2062-2068

[4] Atrial therapies reduce atrial arrhythmia burden in defibrillator patients [J].

Friedman, PA ;

Dijkman, B ;

Warman, EN ;

Xia, A ;

Mehra, R ;

Stanton, MS ;

Hammill, SC .

CIRCULATION, 2001, 104 (09) :1023-1028

[5]

Gallagher R D, 1997, Am J Crit Care, V6, P16

[6] Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias [J].

Gold, MR ;

Sulke, N ;

Schwartzman, DS ;

Mehra, R ;

Euler, DE .

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2001, 12 (11) :1247-1253

[7] QUALITY-OF-LIFE ASSESSMENT IN PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION OR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA [J].

HAMER, ME ;

BLUMENTHAL, JA ;

MCCARTHY, EA ;

PHILLIPS, BG ;

PRITCHETT, ELC .

AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (08) :826-829

[8] Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators [J].

Herrmann, C ;

vonzurMuhen, F ;

Schaumann, A ;

Buss, U ;

Kemper, S ;

Wantzen, C ;

Gonska, BD .

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (01) :95-103

[9]

Jung W, 1998, J CARDIOVASC ELECTR, V9, pS177

[10] EPIDEMIOLOGIC FEATURES OF CHRONIC ATRIAL-FIBRILLATION - THE FRAMINGHAM-STUDY [J].

KANNEL, WB ;

ABBOTT, RD ;

SAVAGE, DD ;

MCNAMARA, PM .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (17) :1018-1022

← 1 2 3 →